Medroxyprogesterone Acetate Injection, Suspension
Product Images NDC 50090-5925

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Medroxyprogesterone Acetate (NDC 50090-5925). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500905925)

Label for medroxyprogesterone acetate injectable suspension, 150 mg/mL, supplied as a 1 mL prefilled syringe by A-S Medication Solutions. The label includes storage instructions to store at 68 to 77 degrees Fahrenheit, a product NDC of 50090-5925, and a lot number field. The label warns to use the single-use syringe and discard after one use. Distributor information is listed as A-S Medication Solutions in Libertyville, Illinois.*

FDA Label Image

Figure 1 (Medroxyprogesterone 01)

A forest plot displaying odds ratios with 95% confidence intervals on a logarithmic scale from various studies comparing risk associated with DMPA use. The plot lists studies by Lee et al. (1987), Paul et al. (1989), WHO (1991), Shapiro et al. (2000), and Li et al. (2012), showing point estimates and confidence intervals, with a vertical line at odds ratio 1 indicating no increased risk. The bottom entries summarize all subjects and DMPA use for 12 months or more.*

FDA Label Image

Chemical Structure (Medroxyprogesterone 02)

Chemical structure of medroxyprogesterone acetate showing its steroidal framework with characteristic rings and functional groups including acetoxy and ketone moieties.*

FDA Label Image

Logo (Medroxyprogesterone 03)

FDA Label Image

Image (Medroxyprogesterone 04)

An educational diagram depicting the relative effectiveness of various birth control methods by number of pregnancies per 100 women per year. It categorizes methods from fewer than 1 pregnancy to 85 or more, including implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, abstinence during fertile days, spermicide, withdrawal, and no birth control.*

FDA Label Image

Logo (Medroxyprogesterone 05)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.